Centerline Biomedical
PrivateLast Round
Series B
Jun 27, 2022
Total Funding Raised
$51.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Centerline Biomedical is a medical technology company that develops a three-dimensional visualization and real-time navigation system aimed at enhancing endovascular procedures while minimizing radiation exposure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centerline Biomedical Comparables
Compare Centerline Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediView XR, Inc. | 84% | |
| Cydar Medical | 84% | |
| Medivis | 76% |
Centerline Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 27, 2022 | ||||
| Grant | Apr 22, 2020 | ||||
| Grant | Sep 12, 2019 | ||||
| Grant | Aug 11, 2018 | ||||
| Grant | Apr 3, 2017 | ||||
Series A | Dec 13, 2016 |
Key People
Founding team and executive leadership
Centerline Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JumpStart Ventures | Series B |
| Cleveland Clinic Ventures | Series B |
| NIH RADx | Grant |
| Ohio Third Frontier | Grant |
| Ohio Third Frontier | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| RIK Enterprises | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 121% MoM, reaching 3.5K.
- Apr 22, 2020
$1.5M grant from NIH RADx and NHLBI
Centerline Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Centerline Biomedical's valuation, stock price, and market status.
Is Centerline Biomedical a public or private company?
Centerline Biomedical is a private company.
What is the current stock price of Centerline Biomedical?
Centerline Biomedical is a private company with no public stock price. No recent secondary market data is available.
How much is Centerline Biomedical worth (valuation)?
Valuation information for Centerline Biomedical is not publicly available.
Can I buy Centerline Biomedical stock?
Centerline Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Centerline Biomedical's last funding round?
Centerline Biomedical's most recent funding round was Series B on June 27, 2022.
Who are the main investors in Centerline Biomedical?
Key investors in Centerline Biomedical include JumpStart Ventures, NIH RADx, GE HealthCare, Ohio Third Frontier, RIK Enterprises.
Will Centerline Biomedical IPO soon?
No public IPO plans have been announced for Centerline Biomedical.
How can I track Centerline Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Centerline Biomedical's secondary market activity and sign up for updates.